openPR Logo
Press release

Future of Contraceptive Devices: Trends, Innovations, and Market Outlook | Major Companies are CooperSurgical, Inc., Pregna International Limited, Reckitt Benckiser Group.

06-30-2025 11:34 AM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Contraceptive Devices Market

Contraceptive Devices Market

The Global Contraceptive Devices Market reached US$ 10.98 billion in 2024 and is expected to reach US$ 19.37 billion by 2033, growing at a CAGR of 6.6% during the forecast period of 2025-2033.

Contraceptive Devices Market is witnessing transformative growth in 2025, driven by evolving consumer demand, technology disruption, and sustainability trends. The newly released market research report by DataM Intelligence offers deep insights into segmentation, competitive landscape, and growth forecasts, helping marketers and decision-makers formulate high-impact strategies.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access):- https://datamintelligence.com/download-sample/contraceptive-devices-market?rk

The contraceptive devices market includes medical tools and products designed to prevent pregnancy. These devices can be barrier-based (like c*ndoms, diaphragms), hormonal (intrauterine devices or IUDs), or implantable systems. Used by both males and females, these devices provide a safe, effective, and often reversible method of family planning and are a vital component of reproductive health.

Market Trends
Rising Awareness & Education: Growing awareness about family planning and reproductive health is driving the adoption of contraceptive devices globally.

Increasing Preference for Long-Acting Reversible Contraceptives (LARCs): Devices like hormonal and copper IUDs are gaining traction due to their high effectiveness and minimal maintenance.

Technological Advancements: Innovation in hormone-releasing IUDs, smart implants, and biodegradable contraceptives is shaping the market.

Shift Toward Female-Controlled Methods: Demand for female-centric contraceptives is increasing, especially in emerging economies with rising female empowerment and healthcare access.

Government and NGO Initiatives: Public sector campaigns promoting safe sex and population control are boosting market penetration, especially in high-fertility regions.

Contraceptive Devices Market: Industry Giants and Emerging Leaders:

CooperSurgical, Inc., Pregna International Limited, Reckitt Benckiser Group, Veru Inc., Bayer AG, Abbvie Inc., EUROGINE, S.L., Mona Lisa N.V., Prosan International BV, and OCON Medical Ltd.

Contraceptive Devices Industry Developments:

Introduction of non-hormonal IUDs with fewer side effects and longer usability.

Development of male contraceptive implants and injectable gels that are under clinical trials.

Expansion of telehealth services offering access to prescription and delivery of contraceptive devices.

Collaborations between contraceptive manufacturers and public health organizations to improve availability in low-income regions.

Launch of smart wearable contraception tracking apps integrated with device usage and menstrual cycle data.

Research Methodology

Our comprehensive research approach leverages a dual-methodology framework that seamlessly integrates qualitative insights with quantitative data analysis to deliver robust market intelligence. The process begins with extensive secondary research, where we meticulously collect information from authoritative industry publications, proprietary databases, and verified market sources. This foundation is strengthened through targeted primary research initiatives, including strategic surveys and in-depth interviews with industry veterans, market experts, and key stakeholders.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/contraceptive-devices-market

Segment Covered in the Contraceptive Devices Market:

By Product Type: C*ndoms, Diaphragms and Cervical Caps, Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-dermal Implants.

By Technology: Hormonal Contraceptives, Barrier Contraceptives.

By Gender: Male, Female.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Channels, Others.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Top-down and bottom-up approach for regional analysis

Regional Analysis for Contraceptive Devices Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)



Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Contraceptive Devices market?

➠ Who are the global key manufacturers of the Contraceptive Devices Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Contraceptive Devices market opportunities and threats faced by the vendors in the global Contraceptive Devices Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Contraceptive Devices market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Looking For Detailed Full Report? Get it here: https://datamintelligence.com/buy-now-page?report=contraceptive-devices-market

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Future of Contraceptive Devices: Trends, Innovations, and Market Outlook | Major Companies are CooperSurgical, Inc., Pregna International Limited, Reckitt Benckiser Group. here

News-ID: 4086647 • Views:

More Releases from DataM Intelligence 4market Research LLP

Secondary Myelofibrosis Treatment Market 2025 | JAK Inhibitors, Targeted Therapies & Personalized Medicine Innovations
Secondary Myelofibrosis Treatment Market 2025 | JAK Inhibitors, Targeted Therapi …
The Secondary Myelofibrosis Treatment Market is experiencing robust growth driven by the increasing prevalence of hematological disorders like polycythemia vera and essential thrombocythemia, which often lead to secondary myelofibrosis. Key growth drivers include advances in molecular research leading to innovative targeted therapies, rising awareness and early diagnosis, and expanding healthcare infrastructure globally. Emerging opportunities lie in personalized medicine approaches, novel pharmacological agents, and increasing clinical trials exploring new treatment options.
Inherited Retinal Disease Treatment Market 2025 | Gene Therapy, Optogenetics & AI-Driven Innovations
Inherited Retinal Disease Treatment Market 2025 | Gene Therapy, Optogenetics & A …
The inherited retinal disease (IRD) treatment market is witnessing robust growth, driven by the rising prevalence of rare genetic eye disorders such as retinitis pigmentosa, Leber congenital amaurosis, and Stargardt disease, coupled with advancements in gene therapy, regenerative medicine, and precision medicine. Valued at approximately USD 12.58 billion in 2025, the market is projected to grow at a CAGR of around 8.5% through 2029, reaching over USD 17 billion, with
Acral Lentiginous Melanoma Treatment Market 2025 | Immunotherapies, Targeted Therapies & Personalized Medicine Advances
Acral Lentiginous Melanoma Treatment Market 2025 | Immunotherapies, Targeted The …
The Acral Lentiginous Melanoma (ALM) treatment market is projected to experience strong growth, driven by factors such as increasing incidence of ALM, rising awareness and early diagnosis, and advances in targeted therapies and immunotherapies. The market size was estimated at approximately USD 1.5 billion in 2024 and is expected to reach around USD 3.2 billion by 2033, growing at a CAGR of about 9.2% from 2026 to 2033. Key growth
Androgen Receptor Inhibitor Market 2025 | Next-Gen Prostate & Breast Cancer Therapies, Combination Treatments & Regional Growth
Androgen Receptor Inhibitor Market 2025 | Next-Gen Prostate & Breast Cancer Ther …
The androgen receptor inhibitor market is witnessing robust growth, primarily driven by the rising prevalence of hormone-driven cancers such as prostate and breast cancer, which remain the dominant applications. The global market size for androgen receptor antagonists is estimated at USD 8 billion in 2025 and is forecast to grow at a CAGR of around 7%, reaching over USD 13 billion by 2033. This growth is fueled by the introduction

All 5 Releases


More Releases for Contraceptive

Prominent Contraceptive Devices Market Trend for 2025: Innovative Products In Th …
What industry-specific factors are fueling the growth of the contraceptive devices market? The rising prevalence of sexually transmitted diseases (STDs) is expected to fuel the growth of the contraceptive device market. STDs, influenced by increased sexual activity and insufficient protection, are on the rise, making contraceptive devices, especially condoms, essential for reducing transmission risks. The UK Health Security Agency reported a 4.7% increase in new STI diagnoses in England in 2023,
Contraceptive Devices Market - Revolutionizing Family Planning: Cutting-Edge Con …
Newark, New Castle, USA: The "Contraceptive Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Contraceptive Devices Market: https://www.growthplusreports.com/report/contraceptive-devices-market/7763 This latest report researches the industry structure, sales, revenue,
Contraceptive Drugs Market: Doctors on the cusp of launching the first male cont …
Contraceptive Drugs Market by Product (Oral Contraceptive Pills, Injectable Contraceptives, and Topical Contraceptives), Age Group (15-24 Years, 25-34 Years, 35-44 Years, and Above 44 Years), and End User (Homecare, Hospitals, and Clinics): Global Opportunity Analysis and Industry Forecast, 2020-2027. Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/9850 The global contraceptive drugs market size was evaluated at $14,324.12 million in 2019, and is estimated to garner $24,412.22 million by 2027, registering a CAGR of 6.9% during
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones
Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones